Background: Herpes simplex virus type 2 (HSV-2) infection is common in persons with HIV. As in other populations, most HIV-infected persons with HSV-2 are unaware that they are infected with this virus. Although well-characterized in the general population, factors associated with undiagnosed HSV-2 infection in HIV-infected populations is less well understood.
Objectives: Our objectives were to determine the seroprevalence of undiagnosed HSV-2 and to identify correlates of HSV-2 infection in HIV-infected persons.
Methods: HIV-infected volunteers without known ano-genital HSV-2 were serologically screened for evidence of HSV-2 infection. We evaluated demographic and behavioral characteristics, STI history, and characteristics of HIV infection to evaluate variables associated with co-infection using logistic regression.
Results: HSV-2 seroprevalence was 61%. Women (P = 0.01), African Americans (P=0.001), and older persons (P=0.005) were more likely to be HSV-2 infected. No differences were observed for HIV risk factor, HIV viral load or CD4 count by HSV-2 serostatus. Illicit drug users were more likely to have coinfection with HIV and HSV-2 (OR1.86, 95% CI 1.13-3.08) and this association was more pronounced among heroin/opiate users (OR=4.73, 95% CI 1.27-17.56; P=0.02). STI history (OR=2.29, 95% CI 1.35-3.88) and specifically gonorrhea (OR=2.36, 95% CI 1.03-5.36), syphilis (OR=2.48, 95% CI 1.27-2.85), or Hepatitis B (OR=2.65, 95% CI 1.24-5.66) was more common in persons with HIV/HSV-2 co-infection. In multivariable analysis, syphilis history (OR=2.05, 95% CI 1.01-4.16), HBV infection (OR=2.26, 95% CI 1.03-4.97) and previous or current use of heroin or opiates (OR=5.11, 95% CI 1.33-19.61) remained statistically significant.
Conclusions: Although the seroprevalence of HSV-2 is higher in HIV-infected patients, previously established predictors of HSV-2 seropositivity apply to this population.
Implications for Programs, Policy, and Research: Predictors of HSV-2 infection are similar between HIV-infected and uninfected persons and may be used in screening strategies to identify those at greatest risk for HSV-2 infection.